.png)
.png)
Women in Biotech - Bristol
Biology for Global good: One Health approaches to sustainability
This event is now SOLD OUT. If you would like to be added to the waiting list please submit your details via the form on the 'waiting list' tab.
The health of humans, animals, plants and the environment are inextricably linked and interdependent and biology holds the key to addressing health and food security whilst still meeting the net zero agenda and protecting the natural world. Our speakers will discuss how increasingly interconnected world with heightened risk from zoonotic disease, anti-microbial resistance and environmental change demonstrate how a collaborative, multi-disciplinary approach is more important than ever.
Join us for the first ever Women in Biotech in Bristol. Come and listen to some inspirational women in the sector, and enjoy the incredible networking that WIB has to offer in the thriving hub at Science Creates.
Kiren Baines
Kiren Baines is the CSO and Co-founder at Extracellular. Bristol based Extracellular, offers cultivated meat and seafood companies, expertise in media and process development and scale up, with the ambition to accelerate the sector. Before joining Extracellular, Kiren led the analytical team at a dedicated bioprocessing CDMO. Here Kiren set the department up and spearheaded the commercial direction of the department. With 10 years of experience in cell and gene therapy, including a PhD at the university of Bristol in cell biology, Kiren has developed expertise in cellular manipulation and characterisation as well as in analytics. Kiren’s passions now lie in translating the skills acquired over the last 10 years to the cultivated meat and seafood industry.
Hannah Curtis
Hannah Curtis is a partner in the Technology & Media Team and a member of the firm’s Life Sciences Sector Group. Hannah works across a number of sectors but has a particular focus on life sciences & healthcare, having studied biological sciences prior to law. Hannah has more than fifteen years’ experience of advising on a broad range of commercial transactions and in particular those with an intellectual property focus within the life sciences sector. She specialises in arrangements relating to in and out licensing, sales and distribution, research and development, manufacturing and supply, collaborations, alliances and joint ventures. During her time with the firm Hannah has been on secondment to the Wellcome Trust, Pfizer and the Nestlé Institute of Health Sciences.
Karima Djacem
Karima is Delivery Lead Scientist at Folium Science where she joined in 2018 as a Research Scientist. She is part of the Senior Leadership Team at Folium Science which has the mission to be the first company to deliver CRISPR to the food chain for precise bacterial control and thus reducing the need to use antibiotics in farmed animals. She has a Doctorate from the French National Centre for Scientific Research (CNRS) at Université Paris-Saclay in Bacteriophage Biology and she has a long-standing interest in bacteriophages therapy and their potential to be used as an alternative to antibiotics. Karima also holds a Master’s degree in Biology and Science, Genome, Cells, Development and Evolution from Université Paris-Saclay and a Master’s degree in Microbiology from University of Science and Technology (USTHB) in Algiers (Algeria).
Catherine Fletcher
Dr Catherine Fletcher is Principal at Science Creates Ventures, a Bristol-based VC firm that invests in early-stage UK deep tech companies. Founded by deep tech entrepreneurs and part of the wider Science Creates deep tech ecosystem, Science Creates Ventures supports companies developing ground-breaking technologies with applications in healthcare, quality of life, and the environment. Catherine joined at the inception of Science Creates Ventures, establishing its core due diligence process and pipeline. She leads on deal execution and portfolio management, including roles on company boards. Catherine has operations and business development experience in early-stage life science companies, a PhD in synthetic organic chemistry from the University of Bristol and over five years of post-doctoral research experience with a particular interest in supramolecular chemistry.
Carolyn Porter
Carolyn Porter is CEO of Cytoseek, a preclinical stage biotech company applying its engineering biology platform technology to develop new transformative cell therapies for cancer. Cytoseek is based in Bristol and backed by a group of local and national investors including Science Creates Ventures, Parkwalk and UKI2S. Carolyn's 20 year career to date has included roles in start-up, large biotech and pharma companies. In the start-up arena she led the formation of 16 companies while at Oxford University across different therapeutic modalities and sat on the Board of 5 of those companies. She also held senior BD roles in several BIA member companies including those in start-up biotech (Oxstem), large biotech (Chiron) and pharma (Novartis) and previously worked in Corporate Finance at Ernst & Young. Carolyn's earlier career included working in Technology Transfer and as a post-doctoral researcher at Oxford University. She has a PhD in Immunology from Trinity College Dublin and an MBA from Warwick University. Carolyn's recent career has been focused on commercialization of early stage innovations from UK Universities via new company formation. In addition to being passionate about translation of UK innovation and the contribution of start-up companies to the UK ecosystem, other topics high on her agenda include diversity and inclusion, skills and training to facilitate up-skilling of her team and raising the profile of the South West region particularly in the Cell and Gene Therapy arena. While at Oxford she was co-founder of a women in tech network and as part of an agenda to raise the profile of the South West she is currently working with other local stakeholders to establish a regional Cell and Gene Therapy network.
16:30 – 17:30 Registration & networking
17:30 – 18:30 Panel and Q&A
18:30 – 20:00 Networking drinks reception
BIA members: £35 +VAT
Non-members: £45 +VAT
By registering for this event you accept our Terms & Conditions.
In case of any issues registering for the event, please contact us at [email protected]
Please complete the below form to be added to the waiting list. We will contact you if a space becomes available.
Thank you to our Event supporter:
Annual Supporters
